THARIMMUNE INC (THAR) Fundamental Analysis & Valuation

NASDAQ:THAR • US4327053090

Current stock price

4.74 USD
+0.26 (+5.8%)
At close:
4.8255 USD
+0.09 (+1.8%)
After Hours:

This THAR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. THAR Profitability Analysis

1.1 Basic Checks

  • THAR had negative earnings in the past year.
  • THAR had a negative operating cash flow in the past year.
  • In the past 5 years THAR always reported negative net income.
  • In the past 5 years THAR always reported negative operating cash flow.
THAR Yearly Net Income VS EBIT VS OCF VS FCFTHAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -134.03%, THAR is doing worse than 81.23% of the companies in the same industry.
  • THAR has a worse Return On Equity (-167.66%) than 65.90% of its industry peers.
Industry RankSector Rank
ROA -134.03%
ROE -167.66%
ROIC N/A
ROA(3y)-179.85%
ROA(5y)-342.76%
ROE(3y)-395.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
THAR Yearly ROA, ROE, ROICTHAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

  • THAR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
THAR Yearly Profit, Operating, Gross MarginsTHAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. THAR Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for THAR has been increased compared to 1 year ago.
  • Compared to 5 years ago, THAR has more shares outstanding
  • THAR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
THAR Yearly Shares OutstandingTHAR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
THAR Yearly Total Debt VS Total AssetsTHAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • An Altman-Z score of 58.11 indicates that THAR is not in any danger for bankruptcy at the moment.
  • THAR has a Altman-Z score of 58.11. This is amongst the best in the industry. THAR outperforms 96.36% of its industry peers.
  • THAR has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • THAR has a Debt to Equity ratio (0.03) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 58.11
ROIC/WACCN/A
WACCN/A
THAR Yearly LT Debt VS Equity VS FCFTHAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

  • THAR has a Current Ratio of 4.98. This indicates that THAR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.98, THAR is in line with its industry, outperforming 55.94% of the companies in the same industry.
  • THAR has a Quick Ratio of 4.98. This indicates that THAR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.98, THAR is in line with its industry, outperforming 57.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.98
Quick Ratio 4.98
THAR Yearly Current Assets VS Current LiabilitesTHAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. THAR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 77.73% over the past year.
EPS 1Y (TTM)77.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 41.09% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y5.23%
EPS Next 2Y41.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
THAR Yearly EPS VS EstimatesTHAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -50 -100 -150 -200 -250

More info and screens

Find the best growth stocksShow best growing peers

1

4. THAR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for THAR. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for THAR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
THAR Price Earnings VS Forward Price EarningsTHAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
THAR Per share dataTHAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

  • THAR's earnings are expected to grow with 41.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.09%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. THAR Dividend Analysis

5.1 Amount

  • No dividends for THAR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

THAR Fundamentals: All Metrics, Ratios and Statistics

THARIMMUNE INC

NASDAQ:THAR (2/17/2026, 8:00:02 PM)

After market: 4.8255 +0.09 (+1.8%)

4.74

+0.26 (+5.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-25
Inst Owners3.2%
Inst Owner Change847.93%
Ins Owners0.98%
Ins Owner Change0%
Market Cap178.84M
Revenue(TTM)N/A
Net Income(TTM)-10.32M
Analysts82.86
Price Target5.1 (7.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 29.06
P/tB 29.06
EV/EBITDA N/A
EPS(TTM)-4.11
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0
BVpS0.16
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -134.03%
ROE -167.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-179.85%
ROA(5y)-342.76%
ROE(3y)-395.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.98
Quick Ratio 4.98
Altman-Z 58.11
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.28%
EPS Next Y5.23%
EPS Next 2Y41.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.67%
OCF growth 3YN/A
OCF growth 5YN/A

THARIMMUNE INC / THAR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for THARIMMUNE INC?

ChartMill assigns a fundamental rating of 2 / 10 to THAR.


What is the valuation status of THARIMMUNE INC (THAR) stock?

ChartMill assigns a valuation rating of 1 / 10 to THARIMMUNE INC (THAR). This can be considered as Overvalued.


Can you provide the profitability details for THARIMMUNE INC?

THARIMMUNE INC (THAR) has a profitability rating of 0 / 10.


Can you provide the financial health for THAR stock?

The financial health rating of THARIMMUNE INC (THAR) is 5 / 10.